Ticker brief
INBX INHIBRX BIOSCIENCES INC
Consumer, Non-cyclical · Biotechnology
last close
$123.93
1 day
-1.1%
14 days
+27.7%
mkt cap
$1.4B
signals 14d
8
authors 14d
4
crowd 14d
-1.3σ
Sentiment — last 14 days
daily mean sentiment, 2026-08-19 → 2026-08-26 · now +0.40 (−1 bearish … +1 bullish)
Who spoke4
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @DGretta_Author | C | -0.32 | 5 | +0.32 |
| @Quantumup1 | C | · | 1 | +0.40 |
| @Brad_E_Schulz | C | · | 1 | +0.10 |
| @PersimmonTI | A | -0.57 | 1 | +0.15 |
Recent signals8of 8 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-26 | @DGretta_Author | +0.80 | Discloses holding INBX and expresses a speculative $300-plus buyout target. | -1.1% | tweet ↗ |
| 2026-08-26 | @DGretta_Author | +0.00 | The holdings hashtag indicates an INBX position, but the stance is otherwise unclear. | -1.1% | tweet ↗ |
| 2026-08-25 | @PersimmonTI | +0.15 | Odd INBX price action prompts speculation that MRK may still be interested, but the stance is uncertain. | +1.0% | tweet ↗ |
| 2026-08-25 | @Brad_E_Schulz | +0.10 | Quantifies strong sector breadth and lists leading stocks. | +1.0% | tweet ↗ |
| 2026-08-25 | @DGretta_Author | +0.35 | Speculates and hopes that Merck will acquire INBX, without reporting a factual deal. | +1.0% | tweet ↗ |
| 2026-08-21 | @DGretta_Author | +0.45 | Highlights a triangle setup, 30% short float and Merck relationship as bullish ingredients. | +19.6% | tweet ↗ |
| 2026-08-21 | @Quantumup1 | +0.40 | Stifel reiterated INBX at Buy with a $325 target and favorable catalyst setup | +19.6% | tweet ↗ |
| 2026-08-19 | @DGretta_Author | +0.00 | Reports INBX short float at 30%. | +22.1% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.